Irish Exports Surge by €6.2 Billion in September, Driven by Pharmaceutical Sector

Dublin: Ireland’s exports rose sharply in September, increasing by more than €6.2 billion to reach €28.5 billion, according to the latest data from the Central Statistics Office (CSO). This represents a 28% year-on-year increase, driven predominantly by strong performance in the medical and pharmaceutical sector, which accounted for more than 65% of total exports.

Pharmaceutical and medical goods worth €18.7 billion were exported during the month—an increase of €7.9 billion, or 73.6%, compared to September last year.

Exports to the United States saw particularly significant growth, more than doubling to €16.3 billion, an increase of €7.2 billion. More than 90% of these exports consisted of chemicals and related products, including pharmaceutical goods.

Imports also recorded growth in September, rising by 4% to €11.1 billion, an increase of €399.2 million compared with the same period last year.

For the first nine months of the year, both exports and imports increased compared to the same period in 2024. Exports climbed by 28% to €212.2 billion, while imports rose by 5.5% to €104.8 billion.

Commenting on the figures, Robert Purdue, Senior Portfolio Manager at global financial services firm Ebury (Ireland), said the strong performance of Ireland’s export sector is encouraging, particularly in light of recent US tariff reductions. However, he cautioned that Ireland’s heavy dependence on pharmaceutical exports presents potential risks.

“The majority of Ireland’s export strength comes from pharmaceuticals,” he noted. “Should the US introduce additional punitive measures targeting this sector, the stability we are seeing could be disrupted. Businesses should remain cautious in the current environment,” Purdue added.

Irish Samachar English News

Kindly click to join WhatsApp group chat to get important news and breaking news from Irish Samachar